Question to the Department of Health and Social Care:

To ask Her Majesty’s Government what field safety notices the Medicines and Healthcare products Regulatory Agency (MHRA) has issued for latrunculin A and latrunculin B; when these substances were first licensed by the MHRA for use in any medicinal products; and whether the MHRA has issued any advice regarding the clinical use of these substances.

Latrunculin A and Latrunculin B are not contained in any licensed medicinal products and the Medicines and Healthcare products Regulatory Agency has not issued any advice regarding the clinical usage of these substances, any field safety notices or other communications.